Mandatory notification of trade


Oslo 25.11.2013 - Director Communication & Corporate Affairs of Bionor Pharma, Hilde Aalling Syvertsen, has today purchased 35.000 Bionor Pharma shares at a price of NOK 2.8967 per share.

Hilde Aalling Syvertsen's holding after the purchase is 793.000 Bionor Pharma shares.

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.

GlobeNewswire